Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study. (Q50598315)
Jump to navigation
Jump to search
scientific article published in February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study. |
scientific article published in February 2017 |
Statements
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study. (English)
1 reference
Aramesh Saremi
1 reference
Scott Howell
1 reference
Dawn C Schwenke
1 reference
Gideon Bahn
1 reference
Paul J Beisswenger
1 reference
Peter D Reaven
1 reference
VADT Investigators
1 reference
1 February 2017
1 reference
40
1 reference
4
1 reference
591-598
1 reference
1 reference
1 reference
1 reference